Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US5358970A · kind A · utility
130Cited by
19References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 1993 |
| Grant date | Oct 25, 1994 |
| Priority date | — |
| Expiry date | Aug 12, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application discloses a method of inhibiting degradation of the antidepressant bupropion hydrochloride in a solid pharmaceutical formulation, so that the pharmaceutical formulation will maintain at least 80% of its initial bupropion potency after one year.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.